Phase 1 Healhty Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.
Healhty
Haisco Pharmaceutical Group Co., Ltd.46 enrolled1 locationNCT07521345
Recruiting
Phase 1
A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants
Healhty
Shanghai WD Pharmaceutical Co., Ltd.12 enrolled1 locationNCT07442591
Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers
Healhty
Il-Yang Pharm. Co., Ltd.86 enrolled1 locationNCT07433556
Recruiting
Phase 1
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
Healhty
University Hospital, Basel, Switzerland20 enrolled1 locationNCT07494214
Recruiting
Phase 1
Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
HealhtyOverweight or Obesity
BrightGene Bio-Medical Technology Co., Ltd.60 enrolled1 locationNCT07224399